Protein Misfolding in Diabetes

Protein misfolding is increasingly recognized as a significant factor in the pathology of diabetes, particularly type 2 diabetes. When proteins such as amylin misfold, they form toxic aggregates that disrupt cellular function and contribute to insulin resistance. These misfolded proteins accumulate in pancreatic islet cells, leading to beta-cell dysfunction and a decline in insulin secretion. This mechanism not only exacerbates hyperglycemia but also promotes inflammation and oxidative stress, further impairing glucose metabolism. Therapeutic strategies aimed at stabilizing protein structures or enhancing the clearance of misfolded proteins may hold promise for improving insulin sensitivity and preserving beta-cell function in diabetic patients. Understanding the role of protein misfolding in diabetes is crucial for developing novel treatments and managing complications associated with the disease.